Skip to main content

Mycophenolic Acid Dosage

Medically reviewed by Last updated on Jan 24, 2024.

Applies to the following strengths: 180 mg; 360 mg

Usual Adult Dose for Organ Transplant - Rejection Prophylaxis

720 mg orally 2 times daily


Use: For prophylaxis of organ rejection in kidney transplant

Usual Pediatric Dose for Organ Transplant - Rejection Prophylaxis

5 years and older:

Note: Pediatric patients with a BSA of 1.19 to 1.58 m2 may be dosed either with three of the 180 mg tablets, or one 180 mg tablet plus one 360 mg tablet 2 times a day. Patients with a BSA greater than 1.58 m2 may be dosed either with four of the 180 mg tablets, or two of the 360 mg tablets twice daily. Pediatric doses for patients with BSA less than 1.19 m2 cannot be accurately administered using currently available formulations of this drug.


Use: For the prophylaxis of organ rejection in pediatric patients 5 years of age and older who are at least 6 months post kidney transplant

Renal Dose Adjustments

Mild to moderate renal impairment: No adjustment recommended.
Severe renal impairment (CrCl less than 25 mL/min): Caution recommended.

Liver Dose Adjustments

No adjustment recommended.


The US FDA requires a Risk Evaluation and Mitigation Strategy (REMS) for mycophenolate. It includes elements to assure safe use. For additional information:



Safety and efficacy have not been established in patients younger than 5 years.

Consult WARNINGS section for additional precautions.


Although dialysis may be used to remove the inactive metabolite mycophenolic acid glucuronide, it would not be expected to remove clinically significant amounts of the active moiety mycophenolic acid. This is in large part due to the high plasma protein binding of mycophenolic acid.

Other Comments

Administration advice:



Patient advice:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.